Curet Myriam 4

What Happened
Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical (ISRG), had equity vest and exercised options on Feb 10, 2026, and sold shares in open-market transactions on Feb 10–11, 2026. Specifically, 943 derivative units converted into common stock (838 RSUs + 105 option shares). Of those, 417 shares were surrendered to cover tax withholding (valued at about $205,514). She also exercised 105 option shares at $229.39 per share (cost ~$24,086) and sold those 105 shares the same day at $494.65 (proceeds ~$51,938). Additional open-market sales of 421 shares occurred on Feb 11 at $494.96 (proceeds ~$208,378). Total reported open-market sale proceeds were about $260,316.

Key Details

• Transaction dates: conversions/exercise on 2026-02-10; open-market sales on 2026-02-10 and 2026-02-11.
• Prices & amounts: 838 RSUs converted @ $0 (vesting); 105 option shares exercised @ $229.39 (cost ~$24,086) then sold @ $494.65 (proceeds ~$51,938); 421 shares sold @ $494.96 (proceeds ~$208,378); 417 shares withheld for taxes valued @ $492.84 ( ~$205,514).
• Proceeds: open-market sales total ≈ $260,316; tax-withheld shares ≈ $205,514.
• Shares owned after transaction: not specified in the provided filing details.
• Footnotes: RSUs vest 25% per year starting Feb 10, 2023 (a portion was withheld for taxes); option and RSU vesting schedules described (F1–F4). The open-market sale was executed under a 10b5-1 trading plan that expires July 29, 2026 (F2).
• Filing timeliness: Reported on 2026-02-11 for transactions on 2026-02-10–11 (filed promptly).

Context
This filing shows routine vesting of RSUs and an option exercise followed by same-day sales (a cashless exercise/settlement pattern). The 417-share disposition was a withholding to cover tax liabilities rather than an open-market sale. The presence of a 10b5-1 plan indicates some sales were pre-arranged, which is common for executives and reduces the implication that the trades reflect short-term trading on inside information.